Interfering with Metabolic Profile of Triple-Negative Breast Cancers Using Rationally Designed Metformin Prodrugs.
Babak MV, Chong KR, Rapta P, Zannikou M, Tang HM, Reichert L, Chang MR, Kushnarev V, Heffeter P, Meier-Menches SM, Lim ZC, Yap JY, Casini A, Balyasnikova IV, Ang WH.
Babak MV, et al. Among authors: tang hm.
Angew Chem Int Ed Engl. 2021 Jun 7;60(24):13405-13413. doi: 10.1002/anie.202102266. Epub 2021 May 6.
Angew Chem Int Ed Engl. 2021.
PMID: 33755286